Genpact Limited Impairment of Long-Lived Assets Held-for-use
Genpact Limited (G) reported Impairment of Long-Lived Assets Held-for-use of $1.38 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2023-03-01
- Genpact Limited impairment of long-lived assets held-for-use for the quarter ending 2022-12-31 was $0.00.
- Genpact Limited impairment of long-lived assets held-for-use for the quarter ending 2022-09-30 was $0.00.
- Genpact Limited impairment of long-lived assets held-for-use for the quarter ending 2022-06-30 was $1.38M, a 1665.38% increase year-over-year.
- Genpact Limited impairment of long-lived assets held-for-use for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- Genpact Limited impairment of long-lived assets held-for-use for fiscal 2022 was $1.38M, a 93.94% increase from fiscal 2021.
- Genpact Limited impairment of long-lived assets held-for-use for fiscal 2021 was $710.00K, a 91.09% decline from fiscal 2020.
- Genpact Limited impairment of long-lived assets held-for-use for fiscal 2020 was $7.97M, a 126.89% increase from fiscal 2019.
- Genpact Limited impairment of long-lived assets held-for-use for fiscal 2019 was $3.51M, a 17.68% decline from fiscal 2018.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month | Impairment of Long-Lived Assets Held-for-use 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $1.38M derived: sum of 3 quarters · filed 2023-03-01 | $1.38M 10-K · filed 2023-03-01 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | $1.38M derived: sum of 2 quarters · filed 2022-11-09 | $1.38M 10-Q · filed 2022-11-09 | $1.17M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2022-06-30 | $1.38M 10-Q · filed 2022-08-09 | $1.38M 10-Q · filed 2022-08-09 | $1.17M derived: sum of 3 quarters · filed 2023-03-01 | $1.17M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | -$205.00K derived: sum of 2 quarters · filed 2023-03-01 | -$205.00K derived: sum of 3 quarters · filed 2023-03-01 | -$127.00K derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-12-31 | -$205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$205.00K derived: sum of 2 quarters · filed 2023-03-01 | -$127.00K derived: sum of 3 quarters · filed 2023-03-01 | $710.00K 10-K · filed 2023-03-01 | $915.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $78.00K derived: sum of 2 quarters · filed 2022-11-09 | $915.00K 10-Q · filed 2022-11-09 | -$1.77M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $78.00K 10-Q · filed 2022-08-09 | $915.00K 10-Q · filed 2022-08-09 | -$1.77M derived: sum of 3 quarters · filed 2023-03-01 | -$1.09M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $837.00K 10-Q · filed 2022-05-10 | -$1.84M derived: sum of 2 quarters · filed 2023-03-01 | -$1.17M derived: sum of 3 quarters · filed 2023-03-01 | $8.80M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.01M derived: sum of 2 quarters · filed 2023-03-01 | $7.97M derived: sum of 3 quarters · filed 2023-03-01 | $7.97M 10-K · filed 2023-03-01 | $14.08M 10-K · filed 2021-03-01 |
| 2020-09-30 | $674.00K 10-Q · filed 2021-11-09 | $10.65M derived: sum of 2 quarters · filed 2021-11-09 | $10.65M 10-Q · filed 2021-11-09 | $10.65M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $9.97M 10-Q · filed 2021-08-09 | $9.97M 10-Q · filed 2021-08-09 | $9.97M derived: sum of 3 quarters · filed 2022-03-01 | $9.97M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $3.51M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $3.51M derived: sum of 3 quarters · filed 2022-03-01 | $3.51M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $3.51M derived: sum of 2 quarters · filed 2020-11-09 | $3.51M 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $3.51M 10-Q · filed 2020-08-10 | $3.51M 10-Q · filed 2020-08-10 | |||
| 2018-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.42M derived: sum of 2 quarters · filed 2021-03-01 | $4.26M derived: sum of 3 quarters · filed 2021-03-01 | $4.26M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $688.00K 10-Q · filed 2018-11-09 | $1.54M derived: sum of 2 quarters · filed 2019-08-09 | $1.54M 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | $850.00K 10-Q · filed 2019-08-09 | ||||
| 2017-12-31 | $8.00M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |